DYRK1A and Parkinson disease: Some of these (FYN, DYRK1A, NOD2, CTSB, SV2C, and ITPKB) may serve as potential PD drug targets due to their involvement in pathways linked to neuroinflammation, autophagy, and neuronal degeneration.